These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18752264)

  • 1. Ethnically diverse causes of Walker-Warburg syndrome (WWS): FCMD mutations are a more common cause of WWS outside of the Middle East.
    Manzini MC; Gleason D; Chang BS; Hill RS; Barry BJ; Partlow JN; Poduri A; Currier S; Galvin-Parton P; Shapiro LR; Schmidt K; Davis JG; Basel-Vanagaite L; Seidahmed MZ; Salih MA; Dobyns WB; Walsh CA
    Hum Mutat; 2008 Nov; 29(11):E231-41. PubMed ID: 18752264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic spectrum of Fukutinopathy: most severe phenotype of Fukutinopathy.
    Yoshioka M
    Brain Dev; 2009 Jun; 31(6):419-22. PubMed ID: 18834683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype.
    Yis U; Uyanik G; Heck PB; Smitka M; Nobel H; Ebinger F; Dirik E; Feng L; Kurul SH; Brocke K; Unalp A; Özer E; Cakmakci H; Sewry C; Cirak S; Muntoni F; Hehr U; Morris-Rosendahl DJ
    Neuromuscul Disord; 2011 Jan; 21(1):20-30. PubMed ID: 20961758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.
    Beltrán-Valero de Bernabé D; Currier S; Steinbrecher A; Celli J; van Beusekom E; van der Zwaag B; Kayserili H; Merlini L; Chitayat D; Dobyns WB; Cormand B; Lehesjoki AE; Cruces J; Voit T; Walsh CA; van Bokhoven H; Brunner HG
    Am J Hum Genet; 2002 Nov; 71(5):1033-43. PubMed ID: 12369018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic identity of Fukuyama-type congenital muscular dystrophy and Walker-Warburg syndrome.
    Toda T; Yoshioka M; Nakahori Y; Kanazawa I; Nakamura Y; Nakagome Y
    Ann Neurol; 1995 Jan; 37(1):99-101. PubMed ID: 7818265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome.
    van Reeuwijk J; Janssen M; van den Elzen C; Beltran-Valero de Bernabé D; Sabatelli P; Merlini L; Boon M; Scheffer H; Brockington M; Muntoni F; Huynen MA; Verrips A; Walsh CA; Barth PG; Brunner HG; van Bokhoven H
    J Med Genet; 2005 Dec; 42(12):907-12. PubMed ID: 15894594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families.
    Chang W; Winder TL; LeDuc CA; Simpson LL; Millar WS; Dungan J; Ginsberg N; Plaga S; Moore SA; Chung WK
    Prenat Diagn; 2009 Jun; 29(6):560-9. PubMed ID: 19266496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in POMT1 are found in a minority of patients with Walker-Warburg syndrome.
    Currier SC; Lee CK; Chang BS; Bodell AL; Pai GS; Job L; Lagae LG; Al-Gazali LI; Eyaid WM; Enns G; Dobyns WB; Walsh CA
    Am J Med Genet A; 2005 Feb; 133A(1):53-7. PubMed ID: 15637732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.
    Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M
    Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyc-O-genetics of Walker-Warburg syndrome.
    van Reeuwijk J; Brunner HG; van Bokhoven H
    Clin Genet; 2005 Apr; 67(4):281-9. PubMed ID: 15733261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Walker-Warburg syndrome.
    Vajsar J; Schachter H
    Orphanet J Rare Dis; 2006 Aug; 1():29. PubMed ID: 16887026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 160 kb deletion in ISPD unmasking a recessive mutation in a patient with Walker-Warburg syndrome.
    Czeschik JC; Hehr U; Hartmann B; Lüdecke HJ; Rosenbaum T; Schweiger B; Wieczorek D
    Eur J Med Genet; 2013 Dec; 56(12):689-94. PubMed ID: 24120487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Walker-Warburg Syndrome: A Case with multiple uncommon features.
    Bedri HA; Mustafa BM; Jadallah YM
    Sudan J Paediatr; 2011; 11(2):59-63. PubMed ID: 27493321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal Presentation of Walker-Warburg Syndrome with Compound Heterozygous
    Zago S; Silvestri E; Arcangeli T; Calisesi M; Romeo C; Parmeggiani G; Parrini E; Cetica V; Guerrini R; Palicelli A; Bonasoni MP
    Fetal Pediatr Pathol; 2023 Apr; 42(2):334-341. PubMed ID: 36048137
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease.
    Cormand B; Pihko H; Bayés M; Valanne L; Santavuori P; Talim B; Gershoni-Baruch R; Ahmad A; van Bokhoven H; Brunner HG; Voit T; Topaloglu H; Dobyns WB; Lehesjoki AE
    Neurology; 2001 Apr; 56(8):1059-69. PubMed ID: 11320179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation.
    van Reeuwijk J; Maugenre S; van den Elzen C; Verrips A; Bertini E; Muntoni F; Merlini L; Scheffer H; Brunner HG; Guicheney P; van Bokhoven H
    Hum Mutat; 2006 May; 27(5):453-9. PubMed ID: 16575835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease.
    Taniguchi K; Kobayashi K; Saito K; Yamanouchi H; Ohnuma A; Hayashi YK; Manya H; Jin DK; Lee M; Parano E; Falsaperla R; Pavone P; Van Coster R; Talim B; Steinbrecher A; Straub V; Nishino I; Topaloglu H; Voit T; Endo T; Toda T
    Hum Mol Genet; 2003 Mar; 12(5):527-34. PubMed ID: 12588800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies.
    Devisme L; Bouchet C; Gonzalès M; Alanio E; Bazin A; Bessières B; Bigi N; Blanchet P; Bonneau D; Bonnières M; Bucourt M; Carles D; Clarisse B; Delahaye S; Fallet-Bianco C; Figarella-Branger D; Gaillard D; Gasser B; Delezoide AL; Guimiot F; Joubert M; Laurent N; Laquerrière A; Liprandi A; Loget P; Marcorelles P; Martinovic J; Menez F; Patrier S; Pelluard F; Perez MJ; Rouleau C; Triau S; Attié-Bitach T; Vuillaumier-Barrot S; Seta N; Encha-Razavi F
    Brain; 2012 Feb; 135(Pt 2):469-82. PubMed ID: 22323514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly.
    Vuillaumier-Barrot S; Bouchet-Séraphin C; Chelbi M; Devisme L; Quentin S; Gazal S; Laquerrière A; Fallet-Bianco C; Loget P; Odent S; Carles D; Bazin A; Aziza J; Clemenson A; Guimiot F; Bonnière M; Monnot S; Bole-Feysot C; Bernard JP; Loeuillet L; Gonzales M; Socha K; Grandchamp B; Attié-Bitach T; Encha-Razavi F; Seta N
    Am J Hum Genet; 2012 Dec; 91(6):1135-43. PubMed ID: 23217329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.